A double-blind randomized multicenter dose-ranging trial of intravenous streptokinase in acute myocardial infarction

This publication has 15 references indexed in Scilit:

• Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction
  The American Journal of Cardiology, 1989
• Do different doses of intravenous streptokinase alter the frequency of coronary reperfusion in acute myocardial infarction?
  The American Journal of Cardiology, 1988
• Thrombolytic Therapy: Current Status
  New England Journal of Medicine, 1988
• Failure of Simple Clinical Measurements to Predict Perfusion Status after Intravenous Thrombolysis
  Annals of Internal Medicine, 1988
• The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.
  Circulation, 1987
• Intravenous Bolus Application of Streptokinase and of Anisoylated Plasminogen Streptokinase Activator Complex in Acute Myocardial Infarction
  Drugs, 1987
• Activation of the fibrinolytic system during intracoronary streptokinase administration
  Journal of the American College of Cardiology, 1987
• The effects of the rate of intravenous infusion of streptokinase and the duration of symptoms on the time interval to reperfusion in patients with acute myocardial infarction.
  Circulation, 1985
• The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards
  Thrombosis Research, 1984
• Intravenous short-term infusion of streptokinase in acute myocardial infarction.
  Circulation, 1983